Results 201 to 210 of about 4,201,815 (397)

The prevalence and comorbidity of mental health and substance use disorders in Scandinavian prisons 2010–2019: a multi-national register study

BMC Psychiatry
Background Mental health disorders are common among people in prison, but their prevalence in the Scandinavian prison population remain unclear.
Anne Bukten, Suvi Virtanen, Morten Hesse, Zheng Chang, Timo Lehmann Kvamme, Birgitte Thylstrup, Torill Tverborgvik, Ingeborg Skjærvø, Marianne R. Stavseth   +8 more
doaj   +1 more source

Identification of the socio-cultural barriers of drug addiction treatment in Iran. [PDF]

Heliyon, 2023
Razaghi E, Farhoudian A, Pilevari A, Noroozi A, Hooshyari Z, Radfar R, Malekinejad M.   +6 more
europepmc   +1 more source

Adolescents--drug abuse and addiction. [PDF]

, 1972
Philip Boyd
openalex   +1 more source

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

Molecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp, Wouter P. R. Verdurmen, Jonas V. Schaefer, Kari Kopra, Gabriela Nagy‐Davidescu, Elodie Richard, Marie‐Julie Nokin, Patrick Ernst, Rastislav Tamaskovic, Martin Schwill, Ralph Degen, Claudia Scholl, David Santamaria, Andreas Plückthun   +13 more
wiley   +1 more source

The Effects of Drug Addiction and Detoxification on the Human Oral Microbiota. [PDF]

Microbiol Spectr, 2023
Zhang J, Liu W, Shi L, Liu X, Wang M, Li W, Yu D, Wang Y, Zhang J, Yun K, Yan J.   +10 more
europepmc   +1 more source

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

Drug Peddling, Addiction, and Criminalism

, 1932
Mary D. Bailey
openalex   +2 more sources

Developments in the Field of Drug Abuse: Proceedings 1974 of the National Association for the Prevention of Addiction to Narcotics. Edward Senay, Vernon Shorty, and Harold Alksne [PDF]

, 1978
Barbara W. Lex
openalex   +1 more source

Volitional social interaction prevents drug addiction in rat models

Nature Neuroscience, 2018
M. Venniro, Michelle Zhang, D. Caprioli, Jennifer K. Hoots, S. Golden, Conor Heins, M. Morales, D. Epstein, Y. Shaham   +8 more
semanticscholar   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source